செங்குத்துகள் கூட்டாளர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from செங்குத்துகள் கூட்டாளர்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In செங்குத்துகள் கூட்டாளர்கள் Today - Breaking & Trending Today

ChrysCapital announces investment in Corona Remedies


ChrysCapital announces investment in Corona Remedies
​ By
IANS
|
Published on
​ Mon, Apr 5 2021 20:57 IST
|
​ 9 Views
 
CFMA sees poetic justice for MF investors through 6 FTMF shut funds case in SC.. Image Source: IANS News
New Delhi, April 5 : ChrysCapital, one of the leading private equity funds in India, has announced its investment in Corona Remedies Private Limited (Corona), one of the country s fastest growing pharmaceutical companies, by acquiring a 27 per cent stake through an entirely secondary deal.
Commenting on the investment, Kshitij Sheth, Director, ChrysCapital, said, ChrysCapital is very excited to partner with Corona in its growth journey. The domestic pharmaceutical market is a large, attractive and resilient market with a healthy outlook. Corona is among the fastest growing companies in the Indian pharmaceutical market with presence in exciting therapeutic areas including cardiology, diabetology and gynae ....

New Delhi , Ankur Mehta , Intas Pharma , Zydus Cadila , Nirav Mehta , Shardul Amarchand Mangaldas , Kshitij Sheth , Corona Remedies Private Limited , Founder Director , Capital Advisors , Vertices Partners , Mankind Pharma , Eris Lifesciences , Torrent Pharma , Ipca Labs , Curatio Healthcare , புதியது டெல்ஹி , அன்குர் மேத்தா , இன்டாஸ் பார்மா , ஜய்துச் காடிலா , நீரவ் மேத்தா , ஷார்துள் அமர்சந்த் மங்கல்தாஸ் , க்ஷித்ிஜ் உறை , கொரோனா வைத்தியம் ப்ரைவேட் வரையறுக்கப்பட்டவை , நிறுவனர் இயக்குனர் , செங்குத்துகள் கூட்டாளர்கள் ,

Indian PE firm ChrysCapital picks 27% stake in Corona Remedies


Indian PE firm ChrysCapital picks 27% stake in Corona Remedies
Photographer: Krisztian Bocsi/Bloomberg
April 5, 2021
Indian homegrown private equity (PE) major ChrysCapital has picked up a 27% stake in Gujarat-based drug manufacturer Corona Remedies through a secondary transaction, according to a press statement issued jointly by the companies on Monday.
While other financial details of the transaction were not disclosed, DealStreetAsia had reported on March 30 that ChrysCapital is close to investing $100 million in Corona Remedies. The report also mentioned that Malaysian PE firm Creador is exiting as part of the transaction.
Creador had acquired a 20% stake in Corona Remedies for Rs 120 crore in 2016. ....

Ankur Mehta , Kirtibhai Mehta , Nirav Mehta , Shardul Amarchand Mangaldas , Kshitij Sheth , Corona Remedies , Capital Advisors , Vertices Partners , அன்குர் மேத்தா , கிர்த்திபைய் மேத்தா , நீரவ் மேத்தா , ஷார்துள் அமர்சந்த் மங்கல்தாஸ் , க்ஷித்ிஜ் உறை , கொரோனா வைத்தியம் , செங்குத்துகள் கூட்டாளர்கள் ,